Identification of autoantibody biomarkers for primary Sjögren's syndrome using protein microarrays

Sjögren's syndrome (SS) is a chronic, progressive autoimmune disease primarily affecting women. Diagnosis of SS requires an invasive salivary gland tissue biopsy and a long delay from the start of the symptoms to final diagnosis has been frequently observed. In this study, we aim to identify sa...

Full description

Saved in:
Bibliographic Details
Published in:Proteomics (Weinheim) Vol. 11; no. 8; pp. 1499 - 1507
Main Authors: Hu, Shen, Vissink, Arjan, Arellano, Martha, Roozendaal, Caroline, Zhou, Hui, Kallenberg, Cees G. M., Wong, David T.
Format: Journal Article
Language:English
Published: Weinheim WILEY-VCH Verlag 01.04.2011
WILEY‐VCH Verlag
Wiley-VCH
Wiley Subscription Services, Inc
Subjects:
ISSN:1615-9853, 1615-9861, 1615-9861
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Sjögren's syndrome (SS) is a chronic, progressive autoimmune disease primarily affecting women. Diagnosis of SS requires an invasive salivary gland tissue biopsy and a long delay from the start of the symptoms to final diagnosis has been frequently observed. In this study, we aim to identify salivary autoantibody biomarkers for primary SS (pSS) using a protein microarray approach. Immune‐response protoarrays were used to profile saliva autoantibodies from patients with pSS (n=14), patients with systemic lupus erythematosus (SLE, n=13), and healthy control subjects (n=13). We identified 24 potential autoantibody biomarkers that can discriminate patients with pSS from both patients with SLE and healthy individuals. Four saliva autoantibody biomarkers, anti‐transglutaminase, anti‐histone, anti‐SSA, and anti‐SSB, were further tested in independent pSS (n=34), SLE (n=34), and healthy control (n=34) subjects and all were successfully validated with ELISA. This study has demonstrated the potential of a high‐throughput protein microarray approach for the discovery of autoantibody biomarkers. The identified saliva autoantibody biomarkers may lead to a clinical tool for simple, noninvasive detection of pSS at low cost.
Bibliography:Colour Online: See the article online to view Fig. 3 in colour
PHS - No. R01DE017593
ark:/67375/WNG-QGMSQFTQ-6
istex:07E075540AAC843959C84DFD4BF792D75E5D6F49
ArticleID:PMIC201000206
3
See the article online to view Fig.
Colour Online
in colour
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
Additional corresponding author: Dr. David T. Wong, E-mail: dtww@ucla.edu
ISSN:1615-9853
1615-9861
1615-9861
DOI:10.1002/pmic.201000206